State-of-the-art facility features the first imaging system of its kind in Saudi Arabia Wetzlar, Germany/Thuwal, Saudi Arabia: The King Abdullah University of Science and Technology (KAUST) and Leica Microsystems inaugurated a new Center of Excellence (CoE) for Optical Microscopy on the University’s campus today. With the new center, KAUST and Leica Microsystems embark on a... Read more
Testing according to customer specifications requires a good understanding of underlying process tolerances. If these tolerances are not well-understood, test-result quality decreases. Rework can cause the unnecessary waste of unique sample material. A lab’s reputation may be at stake. Calibration can help combat these issues in day-to-day lab processing. Periodic calibration helps to ensure: Quality.... Read more
In the simplest terms, calibration compares a reference weight of a known mass with a balance’s measured value. The difference is a balance’s error. The question of whether results are sufficiently accurate depends on process risks, which form the basis of the calibration experience and ensure the measurement quality requirements of your institutional lab are... Read more
Basel, 08 March 2018 Changes to the Roche Enlarged Corporate Executive Committee Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that John C. Reed (1958), MD, PhD, Head of Roche Pharma Research and Early Development (pRED) since 2013, has decided to leave Roche for personal reasons and will return to the United States effective 2... Read more
Basel, 27 February 2018 European Commission approves Roche’s Hemlibra for people with haemophilia A with inhibitors First new medicine in over 20 years to treat people with haemophilia A with inhibitors in Europe Hemlibra demonstrated superior efficacy compared to prior treatment with bypassing agents in two phase III studies in adults, adolescents and children Once-weekly... Read more
Basel, 27 February 2018 European Commission approves Roche’s Hemlibra for people with haemophilia A with inhibitors First new medicine in over 20 years to treat people with haemophilia A with inhibitors in Europe Hemlibra demonstrated superior efficacy compared to prior treatment with bypassing agents in two phase III studies in adults, adolescents and children Once-weekly... Read more
ORLANDO, Fla., Feb. 27, 2018 /PRNewswire/ — Pittcon 2018 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled an expanded portfolio of analytical instruments, consumables, software and services to make technology more available to scientists worldwide, enabling faster, more informed decisions based on advanced scientific data. The Pittcon 2018 Conference and... Read more
MANILA, February 23, 2018 – QIAGEN N.V. today announced the opening of QIAGEN Business Services (QBS) Manila, its new Shared Service Center in the Philippines. The new location in the Cyber Sigma building in Fort Bonifacio, Taguig City, Manila, was officially opened today by Roland Sackers, Chief Financial Officer of QIAGEN, in a ceremony that... Read more
Health Canada licenses four prenatal screening assays for risk assessment of fetal trisomies and pre-eclampsia B·R·A·H·M·S Biomarkers Receive Class III Medical Device System License for Prenatal Screening WALTHAM, Mass., Feb. 15, 2018 /PRNewswire/ — B·R·A·H·M·S GmbH, a part of Thermo Fisher Scientific Inc., today announced that its sFlt-1, PlGF plus, PAPP-A and Free βhCG KRYPTOR... Read more
FRANKLIN LAKES, N.J., Feb. 15, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has completed the previously announced divestitures of its soft tissue core needle biopsy product line and Aspira® product line to Merit Medical Systems, Inc. following receipt of all required regulatory... Read more